Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Human & Experimental Toxicology
|
July 9, 2002
Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model
S Dachir, E Fishbeine, Y Meshulam, et al.
Journal of Animal Science
|
January 1, 1986
Temporal relationship of the pulsatile fluctuation of luteinizing hormone and progesterone in cattle: a time series cross-correlation analysis
M Procknor, S Dachir, R E Owens, et al.
Neuroscience Letters
|
July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
A Fisher, R Brandeis, Z Pittel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2000
Scopolamine bioavailability in combined oral and transdermal delivery
Z Nachum, B Shahal, A Shupak, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1994
Transdermal physostigmine in the treatment of Alzheimer's disease
A Levy, R Brandeis, T A Treves, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Human & Experimental Toxicology
|
July 9, 2002
Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model
S Dachir, E Fishbeine, Y Meshulam, et al.
Journal of Animal Science
|
January 1, 1986
Temporal relationship of the pulsatile fluctuation of luteinizing hormone and progesterone in cattle: a time series cross-correlation analysis
M Procknor, S Dachir, R E Owens, et al.
Neuroscience Letters
|
July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats
A Fisher, R Brandeis, Z Pittel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2000
Scopolamine bioavailability in combined oral and transdermal delivery
Z Nachum, B Shahal, A Shupak, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1994
Transdermal physostigmine in the treatment of Alzheimer's disease
A Levy, R Brandeis, T A Treves, et al.
Page
of 2